A Rare Dose of Opportunity in Philippine Pharma

Acquire a Business and Assets Valued at $127M by a Registered Valuer for a Fraction of the Confirmed Appraisal

Asset-Backed · Debt-Free · Scalable · 25-Year Legacy

Transaction — 100% Acquisition

Price: ₱3,000,000,000 (~USD $54.5M @ PHP55:1)

Includes: All operating assets, contracts, IP, and real estate (titles cleared at close)

Transition: 2-year consultancy / handover from founders

Executive Summary

Independent business valuation: > ₱7.0B (≈ USD $127M)

Real estate (clean-titled): ₱2.5B (≈ USD $45M) — included in sale

Accounts receivable (A/R – Trade): ₱32,355,875 (≈ USD $586,363)

Other BV contributors: IP, long-term contracts, operational goodwill

Status: Liabilities cleared at close — buyer acquires a clean, debt-free entity

Deal Snapshot — Key Numbers

Acquisition type: 100% equity

Asking price (100%): ₱3.0B (~USD $54.5M)

Independent BV: > ₱7.0B (~USD $127M)

Real estate (clean-titled): ₱2.5B (~USD $45M)

A/R – Trade: ₱32.3M (~USD $586k)

Asset Summary — Real Estate & Logistics

Daang Hari, Bacoor City: development land (part of real estate package)

Distribution Center 1 (DC1): Southwoods Industrial Park, 22,000 sq.m.

Distribution Center 2 (DC2): Southwoods Industrial Park, 2,219 sq.m.

Total reported real estate value: ₱2.5B

All titles to be regularised/cleared and loans repaid from sale proceeds.

Why This Business

25+ years of proven trading and distribution history

24,500+ active clients — including Mercury Drug, DOH, LGUs & major hospitals

40+ supplier relationships (local & global)

Embedded government & institutional contracts → strong revenue visibility

Retail & wholesale expansion ready to scale (execution funding in place)

Immediate downside protection: ₱2.5B in clean hard assets

Founders’ support: 2-year consultancy for smooth handover

Market Tailwinds

Philippines OTC pharma: projected to reach USD $12.6B by 2030 (~9% CAGR)

SEA healthcare distribution: USD $18B → USD $26B (2023–2029) (~7% CAGR)

Regional M&A multiples: ~8–13× EBITDA; this deal ~10.7× (inc. real estate)

Investor Pack & Early Access

This opportunity is being exclusively managed by Armada Advisory. A full investor pack including financials, usage metrics, roadmap, compliance, and global go-to-market strategy will be released to qualified parties. NDA required. Register interest early.

Process & Confidentiality

To receive the full Information Memorandum (IM), audited financials and legal pack, you must complete a Confidentiality Agreement quoting Reference: PH108342-01.
The IM will be provided only to verified, qualified parties.

Confidentiality note: Stock photography is used to protect vendor confidentiality; images do not depict actual operations.

Exchange Rate Note: All USD conversions are indicative, based on PHP 55 : 1 USD. Final USD amounts will reflect prevailing exchange rates at the time of transaction.